https://www.selleckchem.com/pr....oducts/acalabrutinib
RESULTS The mean age of patients was 60.55 ± 12.07 (range 31-8 years and the mean BMI of the patients was 17.21 ± 2.31. In the ACEI group, physical functioning and fatigue score changes were significant 1 and 2 months after treatment. The mean of fatigue score decreased significantly in the placebo group. Overall, global health status scores significantly increased in both groups, but other items of QoL did not change significantly. CONCLUSION Overall, our results showed that Captopril does not have a significant positive effect
Like
Comment
Share
